ISPOR - PMU60 Assessing the Readability of Patient-Reported Outcome Measures in Trials for Drugs with Recent FDA Approval

PMU60 Assessing the Readability of Patient-Reported Outcome Measures in Trials for Drugs with Recent FDA Approval

Abstract

Authors

E. Ruzich O. Meyers

Full Text Cite This Article

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now